KT 474
Product Specifications
CAS Number
2432994-31-3
Synonyms
SAR-444656
SKU
C01784-1mg
Target
IRAK
Applications
Immunology & Inflammation
Additionnal Information
KT-474 (SAR444656) is a selective small-molecule degrader of IRAK4 in development for the treatment of TLR/IL-1R–driven autoimmune diseases. KT-474 potently downregulates R848 (TLR7/8) and lipopolysaccharide (LPS) -induced IL-6 and IL-8 production in peripheral blood mononuclear cells (PBMCs) .
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1149627-01 0.02 mg (E-Coli)
Recombinant Phaseolus vulgaris Glucan endo-1,3-beta-glucosidase, basic isoform
Sign In for Pricing
View Details MBS1149627-02 0.02 mg (Yeast)
Recombinant Phaseolus vulgaris Glucan endo-1,3-beta-glucosidase, basic isoform
Sign In for Pricing
View Details 
MBS1149627-03 0.1 mg (E-Coli)
Recombinant Phaseolus vulgaris Glucan endo-1,3-beta-glucosidase, basic isoform
Sign In for Pricing
View Details 
MBS1149627-04 0.1 mg (Yeast)
Recombinant Phaseolus vulgaris Glucan endo-1,3-beta-glucosidase, basic isoform
Sign In for Pricing
View Details MBS1149627-05 0.02 mg (Baculovirus)
Recombinant Phaseolus vulgaris Glucan endo-1,3-beta-glucosidase, basic isoform
Sign In for Pricing
View Details MBS1149627-06 0.02 mg (Mammalian-Cell)
Recombinant Phaseolus vulgaris Glucan endo-1,3-beta-glucosidase, basic isoform
Sign In for Pricing
View Details